Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Leducq Immunomodulation Network (LINK): Immune Modulation of Cardiovascular Disease

European Coordinator:
  • Seppo YLÄ-HERTTUALA, University of Eastern Finland, Kuopio
North American Coordinator:
  • Joseph WITZTUM, University of California, San Diego (USA)
Members:
  • Inder VERMA, The Salk Institute for Biological Studies, La Jolla (USA)
  • Christopher GLASS, University of California, San Diego (USA)
  • Alain TEDGUI, INSERM U689, Hôpital Lariboisière, Paris (France)
  • Bernd BINDER, University of Vienna (Austria)
  • Christoph BINDER, University of Vienna (Austria)
  • Chantal BOULANGER, INSERM U689, Paris (France)
  • M. John CHAPMAN, INSERM U551, Paris (France)
  • Godfrey S. GETZ, University of Chicago (USA)
  • Ziad MALLAT, INSERM U689, Paris (France)
  • Yury MILLER, University of California, San Diego (USA)
  • Catherine REARDON, University of Chicago (USA)
  • Sotiros TSIMIKAS, University of California, San Diego (USA)

Lowering cholesterol (particularly LDL) levels helps to prevent atherosclerosis, the build up of fatty deposits in artery walls. The growth of these deposits, if unchecked, can cause a heart attack or stroke.  Research has recently focused also on the role of inflammation, and the immune system, in this process.  Network investigators are setting out to characterize this role, and to investigate novel treatments developed in light of the knowledge gained about immune disease, such as vaccines to prevent atherosclerosis.